Last10K.com

China Sxt Pharmaceuticals, Inc. (SXTC) SEC Filing 20-F Annual Report for the fiscal year ending Thursday, March 31, 2022

SEC Filings

SXTC Annual Reports

  • 20-F Annual Report July 2022
  • 20-F Annual Report August 2021
    20-F Annual Report July 2020
    20-F Annual Report August 2019

China Sxt Pharmaceuticals, Inc.

CIK: 1723980 Ticker: SXTC

View differences made from one year to another to evaluate China Sxt Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by China Sxt Pharmaceuticals, Inc..

Continue

Assess how China Sxt Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

China Sxt Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders??? Equity
Consolidated Statements Of Income/(Loss) And Comprehensive Income/(Loss)
Accounting Policies, By Policy (Policies)
Accounts Receivable
Accounts Receivable (Details)
Accounts Receivable (Details) - Schedule Of Accounts Receivable
Accounts Receivable (Tables)
Accrued Expenses And Other Liabilities
Accrued Expenses And Other Liabilities (Details)
Accrued Expenses And Other Liabilities (Details) - Schedule Of Accrued Expenses And Other Liabilities
Accrued Expenses And Other Liabilities (Tables)
Bank Loans
Bank Loans (Details)
Bank Loans (Details) - Schedule Of Bank Loans
Bank Loans (Tables)
Commitment
Commitment (Details) - Schedule Of Operating Lease Commitment
Commitment (Tables)
Construction In Process
Construction In Process (Details) - Schedule Of Construction In Process
Construction In Process (Tables)
Convertible Note
Convertible Note (Details)
Convertible Note (Details) - Schedule Of Amortization Of Issuance Cost, Debt Discount And Interest Cost
Convertible Note (Details) - Schedule Of Net Carrying Amount Of Liability
Convertible Note (Details) - Schedule Of Net Carrying Amount Of The Equity Component
Convertible Note (Tables)
Deferred Cost
Deferred Cost (Details)
Guarantee
Guarantee (Details)
Income Taxes
Income Taxes (Details)
Income Taxes (Details) - Schedule Of Deferred Income Tax Assets And Liabilities
Income Taxes (Details) - Schedule Of Income From Operations Before Income Taxes
Income Taxes (Details) - Schedule Of Income Tax Expenses
Income Taxes (Tables)
Intangible Assets, Net
Intangible Assets, Net (Details)
Intangible Assets, Net (Details) - Schedule Of Intangible Assets, Net
Intangible Assets, Net (Tables)
Inventories
Inventories (Details)
Inventories (Details) - Schedule Of Inventories
Inventories (Tables)
Loan Receivable And Accrued Interest
Loan Receivable And Accrued Interest (Details)
Loan Receivable And Accrued Interest (Details) - Schedule Of Loan Receivable And Accrued Interest
Loan Receivable And Accrued Interest (Tables)
Long-Term Deposit
Long-Term Deposit (Details)
Organization And Principal Actitivies
Organization And Principal Actitivies (Details)
Prepayments, Receivables And Other Assets
Prepayments, Receivables And Other Assets (Details)
Prepayments, Receivables And Other Assets (Details) - Schedule Of Prepayments, Receivables And Other Assets
Prepayments, Receivables And Other Assets (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Details)
Property, Plant And Equipment (Details) - Schedule Of Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Refund Liability
Refund Liability (Details)
Related Party Transactions
Related Party Transactions (Details)
Related Party Transactions (Details) - Schedule Of Amount Due To Related Parties
Related Party Transactions (Details) - Schedule Of Nature Of Relationships With Related Parties
Related Party Transactions (Tables)
Shareholders' Equity
Shareholders' Equity (Details)
Significant Accounting Policies
Significant Accounting Policies (Details)
Significant Accounting Policies (Details) - Schedule Of Customer Concentration Risk
Significant Accounting Policies (Details) - Schedule Of Estimated Useful Lives Of The Assets
Significant Accounting Policies (Details) - Schedule Of Exchange Rates
Significant Accounting Policies (Details) - Schedule Of Suppliers Concentration Risk
Significant Accounting Policies (Tables)
Subsequent Events
Subsequent Events (Details)
Ticker: SXTC
CIK: 1723980
Form Type: 20-F Annual Report
Accession Number: 0001213900-22-039838
Submitted to the SEC: Mon Jul 18 2022 11:01:15 AM EST
Accepted by the SEC: Mon Jul 18 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sxtc/0001213900-22-039838.htm